BSEMOTC
BIOSTEM TECHNOLOGIES
Healthcare·Healthcare·Fort Lauderdale, FL, United States
BIOSTEM TECHNOLOGIES (BSEM): 1 clinical trial. Updated within the last hour.
Key Financials
Market Cap
$68.1M
Cash
—
Quarterly Burn
—
Runway
—
Revenue
—
1 clinical trial·CEO: Mr. Jason V. Matuszewski
Frequently asked questions
What is BIOSTEM TECHNOLOGIES's market capitalization?
BIOSTEM TECHNOLOGIES's market capitalization is approximately $68.1M.
Who is the CEO of BIOSTEM TECHNOLOGIES?
Mr. Jason V. Matuszewski is the chief executive officer of BIOSTEM TECHNOLOGIES (BSEM).
Get the full picture on BIOSTEM TECHNOLOGIES
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.